Myoferlin is required for insulin-like growth factor response and muscle growth

FASEB Journal

Volumn 24, Issue 4, 2010, Pages 1284-1295

  Demonbreun, Alexis R ^a   Posey, Avery D ^a   Heretis, Konstantina ^a   Swaggart, Kayleigh A ^a   Earley, Judy U ^a   Pytel, Peter ^a   McNally, Elizabeth M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Lysosome; Myoblast fusion; Receptor trafficking; Signaling

Indexed keywords

MEMBRANE PROTEIN; MYOFERLIN; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; INSULIN LIKE GROWTH FACTOR 1, MOUSE; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MUSCLE PROTEIN; MYOFERLIN PROTEIN, MOUSE; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; ENDOSOME; LYSOSOME; MOUSE; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE REGENERATION; MYOBLAST; MYOTUBE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE MUTANT; MUSCLE FIBRIL; PHYSIOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; CELLS, CULTURED; ENDOSOMES; INSULIN-LIKE GROWTH FACTOR I; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOMES; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; MUSCLE DEVELOPMENT; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; MYOFIBRILS; PROTEIN TRANSPORT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

MUS;

EID: 77951640392     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-136309     Document Type: Article

References (49)

1. Barton, E. R. (2006) The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair. Appl. Physiol. Nutr. Metab. 31, 791-797
2. Musaro, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E. R., Sweeney, H. L., and Rosenthal, N. (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27, 195-200
3. Yang, S. Y., and Goldspink, G. (2002) Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett. 522, 156-160
4. Coleman, M. E., DeMayo, F., Yin, K. C., Lee, H. M., Geske, R., Montgomery, C., and Schwartz, R. J. (1995) Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270, 12109-12116
5. Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59-72
6. Powell-Braxton, L., Hollingshead, P., Warburton, C., Dowd, M., Pitts-Meek, S., Dalton, D., Gillett, N., and Stewart, T. A. (1993) IGF-I is required for normal embryonic growth in mice. Genes Dev. 7, 2609-2617
7. Musaro, A., McCullagh, K. J., Naya, F. J., Olson, E. N., and Rosenthal, N. (1999) IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NFATc1. Nature 400, 581-585
8. Liao, L., Dearth, R. K., Zhou, S., Britton, O. L., Lee, A. V., and Xu, J. (2006) Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency. Endocrinology 147, 3877-3888
9. Mourkioti, F., and Rosenthal, N. (2005) IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol. 26, 535-542
10. Coolican, S. A., Samuel, D. S., Ewton, D. Z., McWade, F. J., and Florini, J. R. (1997) The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272, 6653-6662
11. Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., and Glass, D. J. (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3, 1009-1013
12. Doherty, K. R., and McNally, E. M. (2003) Repairing the tears: dysferlin in muscle membrane repair. Trends Mol. Med. 9, 327-330
13. Bansal, D., Miyake, K., Vogel, S. S., Groh, S., Chen, C. C., Williamson, R., McNeil, P. L., and Campbell, K. P. (2003) Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423, 168-172
14. Doherty, K. R., Cave, A., Davis, D. B., Delmonte, A. J., Posey, A., Earley, J. U., Hadhazy, M., and McNally, E. M. (2005) Normal myoblast fusion requires myoferlin. Development 132, 5565-5575
15. Doherty, K. R., Demonbreun, A. R., Wallace, G. Q., Cave, A., Posey, A. D., Heretis, K., Pytel, P., and McNally, E. M. (2008) The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion. J. Biol. Chem. 283, 20252-20260
16. George, M., Ying, G., Rainey, M. A., Solomon, A., Parikh, P. T., Gao, Q., Band, V., and Band, H. (2007) Shared as well as distinct roles of EHD proteins revealed by biochemical and functional comparisons in mammalian cells and C. elegans. BMC Cell Biol. 8, 3
17. Lynch, G. S., Cuffe, S. A., Plant, D. R., and Gregorevic, P. (2001) IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromuscul. Disord. 11, 260-268
18. McNally, E. M., Duggan, D., Gorospe, J. R., Bonnemann, C. G., Fanin, M., Pegoraro, E., Lidov, H. G., Noguchi, S., Ozawa, E., Finkel, R. S., Cruse, R. P., Angelini, C., Kunkel, L. M., and Hoffman, E. P. (1996) Mutations that disrupt the carboxylterminus of gamma-sarcoglycan cause muscular dystrophy. Hum. Mol. Genet. 5, 1841-1847
19. Manders, E. E. M. (1993) Measurement of co-localisation of objects in dual-colour confocal images. J. Microsc. 169, 375-382
20. Abramoff, M. D. (2004) Image processing with Image J. Biophotonics International 11, 36-42
21. Wiley, H. S., and Cunningham, D. D. (1981) A steady state model for analyzing the cellular binding, internalization and degradation of polypeptide ligands. Cell 25, 433-440
22. Chow, J. C., Condorelli, G., and Smith, R. J. (1998) Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J. Biol. Chem. 273, 4672-4680
23. Schmid, C., Steiner, T., and Froesch, E. R. (1983) Preferential enhancement of myoblast differentiation by insulin-like growth factors (IGF I and IGF II) in primary cultures of chicken embryonic cells. FEBS Lett. 161, 117-121
24. Zapf, A., Hsu, D., and Olefsky, J. M. (1994) Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts. Endocrinology 134, 2445-2452
25. Kalderon, N., and Gilula, N. B. (1979) Membrane events involved in myoblast fusion. J. Cell Biol. 81, 411-425
26. Lefaucheur, J. P., and Sebille, A. (1995) Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I. J. Neuroimmunol. 57, 85-91
27. Nguyen, T. T., Sheppard, A. M., Kaye, P. L., and Noakes, P. G. (2007) IGF-I and insulin activate mitogen-activated protein kinase via the type 1 IGF receptor in mouse embryonic stem cells. Reproduction 134, 41-49
28. Eskelinen, E. L., Illert, A. L., Tanaka, Y., Schwarzmann, G., Blanz, J., Von Figura, K., and Saftig, P. (2002) Role of LAMP-2 in lysosome biogenesis and autophagy. Mol. Biol. Cell 13, 3355-3368
29. Eskelinen, E. L. (2008) Fine structure of the autophagosome. Methods Mol. Biol. 445, 11-28
30. Bakker, A. C., Webster, P., Jacob, W. A., and Andrews, N. W. (1997) Homotypic fusion between aggregated lysosomes triggered by elevated [Ca2]i in fibroblasts. J. Cell Sci. 110(Pt. 18), 2227-2238
31. Cenacchi, G., Fanin, M., De Giorgi, L. B., and Angelini, C. (2005) Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism. J. Clin. Pathol. 58, 190-195
32. Giovannini, S., Marzetti, E., Borst, S. E., and Leeuwenburgh, C. (2008) Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mech. Ageing Dev. 129, 593-601
33. Barton-Davis, E. R., Shoturma, D. I., and Sweeney, H. L. (1999) Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol. Scand. 167, 301-305
34. Davis, D. B., Doherty, K. R., Delmonte, A. J., and McNally, E. M. (2002) Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J. Biol. Chem. 277, 22883-22888
35. Grant, B. D., and Caplan, S. (2008) Mechanisms of EHD/RME-1 protein function in endocytic transport. Traffic 9, 2043-2052
36. Guilherme, A., Soriano, N. A., Bose, S., Holik, J., Bose, A., Pomerleau, D. P., Furcinitti, P., Leszyk, J., Corvera, S., and Czech, M. P. (2004) EHD2 and the novel EH domain binding protein EHBP1 couple endocytosis to the actin cytoskeleton. J. Biol. Chem. 279, 10593-10605
37. Horsley, V., Jansen, K. M., Mills, S. T., and Pavlath, G. K. (2003) IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113, 483-494
38. Jansen, K. M., and Pavlath, G. K. (2006) Mannose receptor regulates myoblast motility and muscle growth. J. Cell Biol. 174, 403-413
39. Yasunaga, S., Grati, M., Cohen-Salmon, M., El-Amraoui, A., Mustapha, M., Salem, N., El-Zir, E., Loiselet, J., and Petit, C. (1999) A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat. Genet. 21, 363-369
40. Roux, I., Safieddine, S., Nouvian, R., Grati, M., Simmler, M. C., Bahloul, A., Perfettini, I., Le Gall, M., Rostaing, P., Hamard, G., Triller, A., Avan, P., Moser, T., and Petit, C. (2006) Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 127, 277-289
41. Heidrych, P., Zimmermann, U., Bress, A., Pusch, C. M., Ruth, P., Pfister, M., Knipper, M., and Blin, N. (2008) Rab8b GTPase, a protein transport regulator, is an interacting partner of otoferlin, defective in a human autosomal recessive deafness form. Hum. Mol. Genet. 17, 3814-3821
42. Henry, L., and Sheff, D. R. (2008) Rab8 regulates basolateral secretory, but not recycling, traffic at the recycling endosome. Mol. Biol. Cell 19, 2059-2068
43. Furlanetto, R. W. (1988) Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells. Endocrinology 122, 2044-2053
44. Mukherjee, S., Tessema, M., and Wandinger-Ness, A. (2006) Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function. Circ. Res. 98, 743-756
45. Edwall, D., Schalling, M., Jennische, E., and Norstedt, G. (1989) Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology 124, 820-825
46. Raben, N., Hill, V., Shea, L., Takikita, S., Baum, R., Mizushima, N., Ralston, E., and Plotz, P. (2008) Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum. Mol. Genet. 17, 3897-3908
47. Meikle, P. J., Yan, M., Ravenscroft, E. M., Isaac, E. L., Hopwood, J. J., and Brooks, D. A. (1999) Altered trafficking and turnover of LAMP-1 in Pompe disease-affected cells. Mol. Genet. Metab. 66, 179-188
48. Anderson, L. V., Davison, K., Moss, J. A., Young, C., Cullen, M. J., Walsh, J., Johnson, M. A., Bashir, R., Britton, S., Keers, S., Argov, Z., Mahjneh, I., Fougerousse, F., Beckmann, J. S., and Bushby, K. M. (1999) Dysferlin is a plasma membrane protein and is expressed early in human development. Hum. Mol. Genet. 8, 855-861
49. Davis, D. B., Delmonte, A. J., Ly, C. T., and McNally, E. M. (2000) Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum. Mol. Genet. 9, 217-226